Insider acquisitions
Explore purchases, stock awards, gifts, exercises, and conversions. These records cover acquisitions only; sales are not included.
Transaction timeline & trade size
Choose a reporting owner, transaction period, and security. Open any point for the filing.
Sep 15, 2025 – Oct 13, 2025 · Transaction dates · Current page sample
Reported transaction sizes · security units
HEICO CORP · Class A Common Stock · Purchase (code P) · Non-derivative · Not reported
Swipe the chart to see the full date range. Exact records are available in the table below.
2 transactions plotted for one security and transaction type. 0 have no reported quantity. A value chart requires a stated currency. Individual reported values remain visible in the table.
50 dated transactions in this page sample · 41 reporting owners.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type | Quantity | Price | Reference value | Currency |
|---|---|---|---|---|---|---|---|
| Oct 12, 2025 | CACI INTERNATIONAL INC /DE/CACI Common Stock | MORRISON SCOTT C (Director) | Exercise / conversion | 83 | Not reported | Not reported | Not reported |
| Oct 10, 2025 | HEICO CORPClass A Common Stock | SCHRIESHEIM ALAN (Director) | Purchase | 672 | 243.934 | 163,923.648 | Not reported |
| Oct 8, 2025 | Stoke Therapeutics, Inc.Restricted Stock Units | SMITH IAN F (Chief Executive Officer · Director) | Stock award | 380,000 | 0 | 0 | Not reported |
| Oct 8, 2025 | Stoke Therapeutics, Inc.Stock Option (Right to Buy) | SMITH IAN F (Chief Executive Officer · Director) | Stock award | 570,000 | 0 | 0 | Not reported |
| Oct 10, 2025 | Victory Capital Holdings, Inc.Common Stock | Rappaport Alan (Director) | Stock award | 1,004 | 65.98 | 66,243.92 | Not reported |
| Oct 10, 2025 | Victory Capital Holdings, Inc.Common Stock | DEMARTINI RICHARD M (Director) | Stock award | 549 | 65.98 | 36,223.02 | Not reported |
| Oct 10, 2025 | Victory Capital Holdings, Inc.Common Stock | Jackson Mary M. (Director) | Stock award | 435 | 65.98 | 28,701.3 | Not reported |
| Oct 10, 2025 | Victory Capital Holdings, Inc.Common Stock | Hirtler-Garvey Karin (Director) | Stock award | 435 | 65.98 | 28,701.3 | Not reported |
| Oct 10, 2025 | Victory Capital Holdings, Inc.Common Stock | Davanzo Lawrence (Director) | Stock award | 435 | 65.98 | 28,701.3 | Not reported |
| Oct 9, 2025 | Zenas BioPharma, Inc.Common Stock | Nunn Jason Raleigh (Director) | Purchase | 63,158 | 19 | 1,200,002 | Not reported |
| Oct 9, 2025 | Zenas BioPharma, Inc.Common Stock | George Simeon (10% owner) · SR ONE CAPITAL MANAGEMENT, LLC (10% owner) | Purchase | 63,157 | 19 | 1,199,983 | Not reported |
| Oct 9, 2025 | Zenas BioPharma, Inc.Common Stock | George Simeon (10% owner) · SR ONE CAPITAL MANAGEMENT, LLC (10% owner) | Purchase | 63,158 | 19 | 1,200,002 | Not reported |
| Oct 13, 2025 | Kymera Therapeutics, Inc.Common Stock | Gollob Jared (Chief Medical Officer) | Exercise / conversion | 673 | 2.08 | 1,399.84 | Not reported |
| Oct 13, 2025 | Kymera Therapeutics, Inc.Common Stock | Gollob Jared (Chief Medical Officer) | Exercise / conversion | 800 | 1.31 | 1,048 | Not reported |
| Oct 9, 2025 | Chewy, Inc.Class A common stock, par value $0.01 | CIE Management IX Ltd (10% owner) · BC Partners Holdings Ltd (10% owner) · Argos Holdings GP LLC (10% owner) · Argos Holdings L.P. (10% owner) · Citrus Intermediate Holdings L.P. (10% owner) | Conversion | 13,280,212 | Not reported | Not reported | Not reported |
| Oct 10, 2025 | AN2 Therapeutics, Inc.Common Stock | Marks Gilbert Lynn (Director) | Stock award | 10,367 | 0 | 0 | Not reported |
| Oct 10, 2025 | AN2 Therapeutics, Inc.Common Stock | Aziz Kabeer (Director) | Stock award | 10,367 | 0 | 0 | Not reported |
| Oct 10, 2025 | AN2 Therapeutics, Inc.Common Stock | Martin Patricia A. (Director) | Stock award | 3,274 | 0 | 0 | Not reported |
| Oct 11, 2025 | Ryman Hospitality Properties, Inc.Common Stock | FIORAVANTI MARK (President & CEO · Director) | Exercise / conversion | 6,966 | 0 | 0 | Not reported |
| Oct 9, 2025 | Zenas BioPharma, Inc.Common Stock | ENRIGHT PATRICK G (Director) | Purchase | 11,990 | 20.85 | 249,991.5 | Not reported |
| Oct 9, 2025 | Zenas BioPharma, Inc.Common Stock | ENRIGHT PATRICK G (Director) | Purchase | 105,265 | 19 | 2,000,035 | Not reported |
| Oct 13, 2025 | Kymera Therapeutics, Inc.Common Stock | Albers Jeffrey W. (Director) | Exercise / conversion | 5,000 | 10.34 | 51,700 | Not reported |
| Oct 1, 2025 | HOULIHAN LOKEY, INC.Class A Common Stock | Mund Ronald Scott (Director) | Stock award | 483 | 0 | 0 | Not reported |
| Oct 10, 2025 | FENNEC PHARMACEUTICALS INC.Common Shares | RALLIS CHRIS A (Director) | Exercise / conversion | 4,062 | 1.23 | 4,996.26 | Not reported |
| Sep 26, 2025 | Main Street Capital CORPCommon Stock | SHIVE DUNIA A (Director) | Other acquisition | 88.3712 | 63.75 | 5,633.664 | Not reported |
| Sep 15, 2025 | Main Street Capital CORPCommon Stock | SHIVE DUNIA A (Director) | Other acquisition | 73.192 | 65.17 | 4,769.92264 | Not reported |
| Oct 10, 2025 | HEICO CORPClass A Common Stock | HENRIQUES ADOLFO (Director) | Purchase | 676 | 243.934 | 164,899.384 | Not reported |
| Oct 10, 2025 | Xos, Inc.Common Stock | RAPP EDWARD J (Director) | Stock award | 1,883 | 0 | 0 | Not reported |
| Oct 10, 2025 | Applied Digital Corp.Common Stock | Cummins Wes (CEO; Chairman · Director · 10% owner) | Exercise / conversion | 200,000 | Not reported | Not reported | Not reported |
| Oct 9, 2025 | WILLIS TOWERS WATSON PLCRestricted Share Unit | Qureshi Imran Ahmed (Head of North America) | Stock award | 4.9466 | 337.39 | 1,668.933374 | Not reported |
| Oct 9, 2025 | WILLIS TOWERS WATSON PLCRestricted Share Unit | Qureshi Imran Ahmed (Head of North America) | Stock award | 41.0548 | 337.39 | 13,851.478972 | Not reported |
| Oct 9, 2025 | WILLIS TOWERS WATSON PLCRestricted Share Unit | Pullum Anne (Head of Europe) | Stock award | 7.0785 | 337.39 | 2,388.215115 | Not reported |
| Oct 9, 2025 | WILLIS TOWERS WATSON PLCRestricted Share Unit | Pullum Anne (Head of Europe) | Stock award | 44.4396 | 337.39 | 14,993.476644 | Not reported |
| Oct 9, 2025 | WILLIS TOWERS WATSON PLCRestricted Share Unit | Kurpis Joseph Stephen (PAO and Controller) | Stock award | 33.393 | 337.39 | 11,266.46427 | Not reported |
| Oct 9, 2025 | WILLIS TOWERS WATSON PLCRestricted Share Unit | Banas Kristy D (Chief Human Resources Officer) | Stock award | 2.4861 | 337.39 | 838.785279 | Not reported |
| Oct 9, 2025 | WILLIS TOWERS WATSON PLCRestricted Share Unit | Banas Kristy D (Chief Human Resources Officer) | Stock award | 37.1447 | 337.39 | 12,532.250333 | Not reported |
| Oct 9, 2025 | WILLIS TOWERS WATSON PLCRestricted Share Unit | Krasner Andrew Jay (Chief Financial Officer) | Stock award | 11.9544 | 337.39 | 4,033.295016 | Not reported |
| Oct 9, 2025 | WILLIS TOWERS WATSON PLCRestricted Share Unit | Krasner Andrew Jay (Chief Financial Officer) | Stock award | 56.8731 | 337.39 | 19,188.415209 | Not reported |
| Oct 9, 2025 | WILLIS TOWERS WATSON PLCRestricted Share Unit | Furman Matthew (General Counsel) | Stock award | 6.8313 | 337.39 | 2,304.812307 | Not reported |
| Oct 9, 2025 | WILLIS TOWERS WATSON PLCRestricted Share Unit | Furman Matthew (General Counsel) | Stock award | 183.8719 | 337.39 | 62,036.540341 | Not reported |
| Oct 9, 2025 | WILLIS TOWERS WATSON PLCRestricted Share Unit | Gebauer Julie Jarecke (Pres.-Health, Wealth & Career) | Stock award | 11.7246 | 337.39 | 3,955.762794 | Not reported |
| Oct 9, 2025 | WILLIS TOWERS WATSON PLCRestricted Share Unit | Gebauer Julie Jarecke (Pres.-Health, Wealth & Career) | Stock award | 156.6178 | 337.39 | 52,841.279542 | Not reported |
| Oct 9, 2025 | WILLIS TOWERS WATSON PLCRestricted Share Unit | Hess Carl Aaron (Chief Executive Officer · Director) | Stock award | 14.9537 | 337.39 | 5,045.228843 | Not reported |
| Oct 9, 2025 | WILLIS TOWERS WATSON PLCRestricted Share Unit | Hess Carl Aaron (Chief Executive Officer · Director) | Stock award | 71.0922 | 337.39 | 23,985.797358 | Not reported |
| Oct 9, 2025 | WILLIS TOWERS WATSON PLCRestricted Share Unit | Faber Alexis (Chief Operating Officer) | Stock award | 4.8346 | 337.39 | 1,631.145694 | Not reported |
| Oct 9, 2025 | WILLIS TOWERS WATSON PLCRestricted Share Unit | Faber Alexis (Chief Operating Officer) | Stock award | 124.4529 | 337.39 | 41,989.163931 | Not reported |
| Oct 13, 2025 | Roivant Sciences Ltd.Common Shares | Venker Eric (President & Immunovant CEO) | Exercise / conversion | 20,727 | 15.85 | 328,522.95 | Not reported |
| Oct 9, 2025 | Roivant Sciences Ltd.Common Shares | Venker Eric (President & Immunovant CEO) | Exercise / conversion | 104,940 | 15.85 | 1,663,299 | Not reported |
| Oct 13, 2025 | ANGIODYNAMICS INCCommon Stock | Trowbridge Stephen A (EVP and CFO) | Purchase | 890 | 11.16 | 9,932.4 | Not reported |
| Oct 13, 2025 | Salesforce, Inc.Common Stock | Benioff Marc (Chair and CEO · Director) | Exercise / conversion | 2,250 | 161.5 | 363,375 | Not reported |
Only transactions on this page are shown. Preset date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Transaction details
Reporting owners, quantities, prices, and source filings.
| Filed / transacted | Company | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|---|
| Transacted: | CACI INTERNATIONAL INC /DE/CACI · company listings | MORRISON SCOTT CDirector | Exercise / conversionCACI Common StockNon-derivative security · Code M | 83 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | HEICO CORPHEI · HEI-A · company listings | SCHRIESHEIM ALANDirector | PurchaseClass A Common StockNon-derivative security · Code P | 672 | 243.934Value: 163,923.648Not reported | View ↗ |
| Transacted: | Stoke Therapeutics, Inc.STOK · company listings | SMITH IAN FChief Executive Officer · Director | Stock awardRestricted Stock UnitsDerivative security · Code A | 380,000 | 0Value: 0Not reported | View ↗ |
| Transacted: | Stoke Therapeutics, Inc.STOK · company listings | SMITH IAN FChief Executive Officer · Director | Stock awardStock Option (Right to Buy)Derivative security · Code A | 570,000 | 0Value: 0Not reported | View ↗ |
| Transacted: | Victory Capital Holdings, Inc.VCTR · company listings | Rappaport AlanDirector | Stock awardCommon StockNon-derivative security · Code A | 1,004 | 65.98 *Value: 66,243.92Not reported | View ↗ |
| Transacted: | Victory Capital Holdings, Inc.VCTR · company listings | DEMARTINI RICHARD MDirector | Stock awardCommon StockNon-derivative security · Code A | 549 | 65.98 *Value: 36,223.02Not reported | View ↗ |
| Transacted: | Victory Capital Holdings, Inc.VCTR · company listings | Jackson Mary M.Director | Stock awardCommon StockNon-derivative security · Code A | 435 | 65.98 *Value: 28,701.3Not reported | View ↗ |
| Transacted: | Victory Capital Holdings, Inc.VCTR · company listings | Hirtler-Garvey KarinDirector | Stock awardCommon StockNon-derivative security · Code A | 435 | 65.98 *Value: 28,701.3Not reported | View ↗ |
| Transacted: | Victory Capital Holdings, Inc.VCTR · company listings | Davanzo LawrenceDirector | Stock awardCommon StockNon-derivative security · Code A | 435 | 65.98 *Value: 28,701.3Not reported | View ↗ |
| Transacted: | Zenas BioPharma, Inc.ZBIO · company listings | Nunn Jason RaleighDirector | PurchaseCommon StockNon-derivative security · Code P | 63,158 | 19Value: 1,200,002Not reported | View ↗ |
| Transacted: | Zenas BioPharma, Inc.ZBIO · company listings | George Simeon10% owner SR ONE CAPITAL MANAGEMENT, LLC10% owner Joint filing · amounts unallocated | PurchaseCommon StockNon-derivative security · Code P | 63,157 | 19Value: 1,199,983Not reported | View ↗ |
| Transacted: | Zenas BioPharma, Inc.ZBIO · company listings | George Simeon10% owner SR ONE CAPITAL MANAGEMENT, LLC10% owner Joint filing · amounts unallocated | PurchaseCommon StockNon-derivative security · Code P | 63,158 | 19Value: 1,200,002Not reported | View ↗ |
| Transacted: | Kymera Therapeutics, Inc.KYMR · company listings | Gollob JaredChief Medical Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 673 | 2.08Value: 1,399.84Not reported | View ↗ |
| Transacted: | Kymera Therapeutics, Inc.KYMR · company listings | Gollob JaredChief Medical Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 800 | 1.31Value: 1,048Not reported | View ↗ |
| Transacted: | Chewy, Inc.CHWY · company listings | CIE Management IX Ltd10% owner BC Partners Holdings Ltd10% owner Argos Holdings GP LLC10% owner Argos Holdings L.P.10% owner Citrus Intermediate Holdings L.P.10% owner Joint filing · amounts unallocated | ConversionClass A common stock, par value $0.01Non-derivative security · Code C | 13,280,212 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | AN2 Therapeutics, Inc.ANTX · company listings | Marks Gilbert LynnDirector | Stock awardCommon StockNon-derivative security · Code A | 10,367 | 0Value: 0Not reported | View ↗ |
| Transacted: | AN2 Therapeutics, Inc.ANTX · company listings | Aziz KabeerDirector | Stock awardCommon StockNon-derivative security · Code A | 10,367 | 0Value: 0Not reported | View ↗ |
| Transacted: | AN2 Therapeutics, Inc.ANTX · company listings | Martin Patricia A.Director | Stock awardCommon StockNon-derivative security · Code A | 3,274 | 0Value: 0Not reported | View ↗ |
| Transacted: | Ryman Hospitality Properties, Inc.RHP · company listings | FIORAVANTI MARKPresident & CEO · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 6,966 | 0Value: 0Not reported | View ↗ |
| Transacted: | Zenas BioPharma, Inc.ZBIO · company listings | ENRIGHT PATRICK GDirector | PurchaseCommon StockNon-derivative security · Code P | 11,990 | 20.85 *Value: 249,991.5Not reported | View ↗ |
| Transacted: | Zenas BioPharma, Inc.ZBIO · company listings | ENRIGHT PATRICK GDirector | PurchaseCommon StockNon-derivative security · Code P | 105,265 | 19 *Value: 2,000,035Not reported | View ↗ |
| Transacted: | Kymera Therapeutics, Inc.KYMR · company listings | Albers Jeffrey W.Director | Exercise / conversionCommon StockNon-derivative security · Code M | 5,000 | 10.34Value: 51,700Not reported | View ↗ |
| Transacted: | HOULIHAN LOKEY, INC.HLI · company listings | Mund Ronald ScottDirector | Stock awardClass A Common StockNon-derivative security · Code A | 483 | 0 *Value: 0Not reported | View ↗ |
| Transacted: | FENNEC PHARMACEUTICALS INC.FENC · company listings | RALLIS CHRIS ADirector | Exercise / conversionCommon SharesNon-derivative security · Code M | 4,062 | 1.23Value: 4,996.26Not reported | View ↗ |
| Transacted: | Main Street Capital CORPMAIN · company listings | SHIVE DUNIA ADirector | Other acquisitionCommon StockNon-derivative security · Code J | 88.3712 | 63.75Value: 5,633.664Not reported | View ↗ |
| Transacted: | Main Street Capital CORPMAIN · company listings | SHIVE DUNIA ADirector | Other acquisitionCommon StockNon-derivative security · Code J | 73.192 | 65.17Value: 4,769.92264Not reported | View ↗ |
| Transacted: | HEICO CORPHEI · HEI-A · company listings | HENRIQUES ADOLFODirector | PurchaseClass A Common StockNon-derivative security · Code P | 676 | 243.934Value: 164,899.384Not reported | View ↗ |
| Transacted: | Xos, Inc.XOS · company listings | RAPP EDWARD JDirector | Stock awardCommon StockNon-derivative security · Code A | 1,883 | 0Value: 0Not reported | View ↗ |
| Transacted: | Applied Digital Corp.APLD · company listings | Cummins WesCEO; Chairman · Director · 10% owner | Exercise / conversionCommon StockNon-derivative security · Code M | 200,000 | Not reported *Value: Not reportedNot reported | View ↗ |
| Transacted: | WILLIS TOWERS WATSON PLCWTW · company listings | Qureshi Imran AhmedHead of North America | Stock awardRestricted Share UnitDerivative security · Code A | 4.9466 | 337.39Value: 1,668.933374Not reported | View ↗ |
| Transacted: | WILLIS TOWERS WATSON PLCWTW · company listings | Qureshi Imran AhmedHead of North America | Stock awardRestricted Share UnitDerivative security · Code A | 41.0548 | 337.39Value: 13,851.478972Not reported | View ↗ |
| Transacted: | WILLIS TOWERS WATSON PLCWTW · company listings | Pullum AnneHead of Europe | Stock awardRestricted Share UnitDerivative security · Code A | 7.0785 | 337.39Value: 2,388.215115Not reported | View ↗ |
| Transacted: | WILLIS TOWERS WATSON PLCWTW · company listings | Pullum AnneHead of Europe | Stock awardRestricted Share UnitDerivative security · Code A | 44.4396 | 337.39Value: 14,993.476644Not reported | View ↗ |
| Transacted: | WILLIS TOWERS WATSON PLCWTW · company listings | Kurpis Joseph StephenPAO and Controller | Stock awardRestricted Share UnitDerivative security · Code A | 33.393 | 337.39Value: 11,266.46427Not reported | View ↗ |
| Transacted: | WILLIS TOWERS WATSON PLCWTW · company listings | Banas Kristy DChief Human Resources Officer | Stock awardRestricted Share UnitDerivative security · Code A | 2.4861 | 337.39Value: 838.785279Not reported | View ↗ |
| Transacted: | WILLIS TOWERS WATSON PLCWTW · company listings | Banas Kristy DChief Human Resources Officer | Stock awardRestricted Share UnitDerivative security · Code A | 37.1447 | 337.39Value: 12,532.250333Not reported | View ↗ |
| Transacted: | WILLIS TOWERS WATSON PLCWTW · company listings | Krasner Andrew JayChief Financial Officer | Stock awardRestricted Share UnitDerivative security · Code A | 11.9544 | 337.39Value: 4,033.295016Not reported | View ↗ |
| Transacted: | WILLIS TOWERS WATSON PLCWTW · company listings | Krasner Andrew JayChief Financial Officer | Stock awardRestricted Share UnitDerivative security · Code A | 56.8731 | 337.39Value: 19,188.415209Not reported | View ↗ |
| Transacted: | WILLIS TOWERS WATSON PLCWTW · company listings | Furman MatthewGeneral Counsel | Stock awardRestricted Share UnitDerivative security · Code A | 6.8313 | 337.39Value: 2,304.812307Not reported | View ↗ |
| Transacted: | WILLIS TOWERS WATSON PLCWTW · company listings | Furman MatthewGeneral Counsel | Stock awardRestricted Share UnitDerivative security · Code A | 183.8719 | 337.39Value: 62,036.540341Not reported | View ↗ |
| Transacted: | WILLIS TOWERS WATSON PLCWTW · company listings | Gebauer Julie JareckePres.-Health, Wealth & Career | Stock awardRestricted Share UnitDerivative security · Code A | 11.7246 | 337.39Value: 3,955.762794Not reported | View ↗ |
| Transacted: | WILLIS TOWERS WATSON PLCWTW · company listings | Gebauer Julie JareckePres.-Health, Wealth & Career | Stock awardRestricted Share UnitDerivative security · Code A | 156.6178 | 337.39Value: 52,841.279542Not reported | View ↗ |
| Transacted: | WILLIS TOWERS WATSON PLCWTW · company listings | Hess Carl AaronChief Executive Officer · Director | Stock awardRestricted Share UnitDerivative security · Code A | 14.9537 | 337.39Value: 5,045.228843Not reported | View ↗ |
| Transacted: | WILLIS TOWERS WATSON PLCWTW · company listings | Hess Carl AaronChief Executive Officer · Director | Stock awardRestricted Share UnitDerivative security · Code A | 71.0922 | 337.39Value: 23,985.797358Not reported | View ↗ |
| Transacted: | WILLIS TOWERS WATSON PLCWTW · company listings | Faber AlexisChief Operating Officer | Stock awardRestricted Share UnitDerivative security · Code A | 4.8346 | 337.39Value: 1,631.145694Not reported | View ↗ |
| Transacted: | WILLIS TOWERS WATSON PLCWTW · company listings | Faber AlexisChief Operating Officer | Stock awardRestricted Share UnitDerivative security · Code A | 124.4529 | 337.39Value: 41,989.163931Not reported | View ↗ |
| Transacted: | Roivant Sciences Ltd.ROIV · company listings | Venker EricPresident & Immunovant CEO | Exercise / conversionCommon SharesNon-derivative security · Code M | 20,727 | 15.85Value: 328,522.95Not reported | View ↗ |
| Transacted: | Roivant Sciences Ltd.ROIV · company listings | Venker EricPresident & Immunovant CEO | Exercise / conversionCommon SharesNon-derivative security · Code M | 104,940 | 15.85Value: 1,663,299Not reported | View ↗ |
| Transacted: | ANGIODYNAMICS INCANGO · company listings | Trowbridge Stephen AEVP and CFO | PurchaseCommon StockNon-derivative security · Code P | 890 | 11.16Value: 9,932.4Not reported | View ↗ |
| Transacted: | Salesforce, Inc.CRM · company listings | Benioff MarcChair and CEO · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 2,250 | 161.5Value: 363,375Not reported | View ↗ |
50 transactions on this page. Filing date, newest first.
Filters use the date a filing was submitted, not the date of the transaction. Coverage is incomplete while historical records are being loaded. How we organize the data →